Eli Lilly CEO David Ricks joins 'Squawk on the Street' to discuss the company's drug pipeline, 2025 outlook, state of the ...

Get access to Brad Slager's "Riffed From the Headlines," a daily VIP feature where he looks to bring accountability to the ...

Eli Lilly forecasts $45 billion revenue for 2024, 32% higher than last year. Medicare changes and stocking issues impact the revised guidance.

Sales results disclosed Tuesday raised concern that investors may have overestimated the demand for Zepbound and Mounjaro.

Brian Bradley and Rick Peckham remain a part of the Lightning after careers with the team that began in the 1990s. They will ...

The shooting happened last night near the campus of Clayton State University. David Lynch, Twin Peaks and Elephant Man director, dies aged 78 Here’s What The Small Panel On Your Car’s Front Bumper Is ...

Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which ...

The updated guidance, which was largely driven by lower-than-anticipated sales of GLP-1 blockbusters Mounjaro and Zepbound, ...

Hiring a private fire crew costs thousands of dollars a day, and most work through government contracts or with insurance ...

In its first conference of 2025, members of the Michigan Supreme Court voted unanimously to retain Elizabeth Clement as the ...

We recently compiled a list of the Jim Cramer Discusses Joe Rogan, Elon Musk, And These 13 Stocks. In this article, we are ...

Heading into fiscal 2025, CEO David Ricks said the company expects sales of weight-loss drugs will continue growing, and noted that it expects "to produce at least 60% more salable doses" of the drugs ...